[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +17%
6 Months: XX% +12%
1 Year: XX% +7%
1-Year High: XX% on 2025-05-12
1-Year Low: X% on 2025-01-28
Most Supportive Themes
- Weight Loss Benefits and Positive Experiences: (38%) Users are sharing positive experiences with Ozempic, highlighting its effectiveness in weight loss and improved health outcomes.
- Novo Nordisk's Price Cuts: (15%) Novo Nordisk is cutting the price of Ozempic for cash-paying patients, making it more accessible.
- Canadian Approval for Kidney Disease: (5%) Ozempic has been approved in Canada to reduce the risk of kidney failure and cardiovascular death in type X diabetes patients.
Most Critical Themes
- Lawsuits and Side Effects: (40%) Numerous lawsuits are being filed against Novo Nordisk alleging severe side effects from Ozempic, including gastroparesis and vision loss.
- Financial Setbacks and Competition: (5%) Novo Nordisk faces challenges, including a missed maintenance fee, competition from Eli Lilly, and a hiring freeze.
- Concerns about Long-Term Effects: (5%) There are concerns about the long-term effects of Ozempic, including the potential for weight regain after stopping the medication.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| News | XX | X% | XX | X% | XX | X% |
| XXX | X% | XXX | X% | XXX | X% | |
| TikTok | XXX | X% | XXX | X% | XXX | X% |
| X | XXX | X% | XXX | X% | XXX | X% |
| YouTube | XXX | X% | XXXXX | X% | XXX | X% |
| Total | XXXXX | X% | XXXXX | X% | XXXXX | X% |